REDRESSing the balance of healthcare for people with sickle cell
The REDRESS study is a clinical trial researching the use of stem cell transplant (also known as bone marrow transplant) to treat people with severe sickle cell disorder (SCD).
Led by a multi-disciplinary group of researchers
This study is being led by a group of researchers based at King’s College Hospital NHS Foundation Trust, University College London Hospitals NHS Foundation Trust and Guy’s & St Thomas’ NHS Foundation Trust.
The trial is managed by the team at King’s Clinical Trials Unit (KCTU) at King’s College London.
The study is sponsored by King’s College Hospital NHS Foundation Trust (Chief Investigator – Dr Victoria Potter) and funded by the National Institute of Health Research (NIHR).
Latest news
Featured
Latest X Posts
- 🩸 Today is Sickle Cell Awareness Day. We're proud to be part of the effort to improve outcomes through the REDRESS Trial, exploring curative options for people living with sickle cell disorder. #SickleCellAwareness #REDRESSTrial #ClinicalResearch #SickleCell
- Congratulations to Dr Farhan Anjum at the team at @MFT_MRI for recruiting their first participant to the #redresstrial. Hopefully the first of many! #sicklecell #research
- Congratulations to Dr Ben Carpenter and the team at @uclh for recruiting the first participant to the #redresstrial and getting off the mark! #sickle #research
